FindTrial
Sign In

Establishing Normal and Reference Values for Aortic Stiffness in Chinese Population: ENVASC Study

Establishing Normal and Reference Values for Aortic Stiffness in Chinese Population

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200064749
Enrollment
Unknown
Registered
2022-10-15
Start date
2022-10-15
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy population

Interventions

Observation group:None

Sponsors

Department of Ultrasound Medicine, Tangdu Hospital, Fourth Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Han nationality and age>=18 years old, male: female=1:1; 2. Have not taken antihypertensive, lipid-lowering, or hypoglycemic drugs and have normal blood sugar and blood pressure levels; 3. No clear cardiovascular diseases (such as hypertension, stroke, coronary heart disease, etc.), metabolic diseases, malignant tumors, or autoimmune diseases; 4. In a hemodynamic stable state.

Exclusion criteria

Exclusion criteria: 1. Significant arrhythmia; 2. Severe stenosis of the carotid and/or femoral arteries (causing significant abnormalities in blood flow spectrum); 3. Anatomical variations of the aorta and its main branches.

Design outcomes

Primary

MeasureTime frame
carotid-femoral Pulse Wave Velocity;heart-femoral Pulse Wave Velocity;—

Countries

China

Contacts

Public ContactLijun Yuan

Department of Ultrasound Medicine, Tangdu Hospital, Fourth Military Medical University

lijunyuan@fmmu.edu.cn+86 29 84777471

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026